Professor Carol Holland on developments in Alzheimer's treatment

Education
Comment must not exceed 1000 characters

The announcement of lecanemab as a treatment for Alzheimer's offers hope to millions of people around the world. Director of Lancaster University's Centre for Ageing Research, Professor Carol Holland, talks about that development and sets it in the context of current work and research around non-drug treatments for Alzheimer's and dementia.

Seems a little quiet over here

Be the first to comment on this track